Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 7,756 | 12,440 | 982 | 0 |
| Operating Income | -7,756 | -12,440 | -982 | N/A |
| Other Income | 78 | 0 | 150 | 0 |
| Pre-tax Income | -7,678 | -12,440 | -832 | 0 |
| Net Income Continuous | -7,678 | -12,440 | -832 | N/A |
| Net Income | $-7,678 | $-12,440 | $-832 | $N/A |
| EPS Basic Total Ops | -0.75 | -1.43 | -0.13 | N/A |
| EPS Basic Continuous Ops | -0.75 | -1.43 | -0.13 | N/A |
| EPS Diluted Total Ops | -0.75 | -1.43 | -0.13 | N/A |
| EPS Diluted Continuous Ops | -0.75 | -1.43 | -0.13 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.75 | N/A | N/A | N/A |
| EBITDA(a) | $-7,756 | $-12,440 | $-982 | $N/A |